SCI Innovation Awards

In keeping with its core mission, the Stanford Cancer Institute has been dedicated to advancing cancer research through the SCI Innovation Awards program since 2013. The awards support projects focused on accelerating basic, translational, clinical, and population-based cancer research and projects focused on specific types of cancer, such as pancreatic, breast, gynecologic, and sarcoma cancers. We strongly encourage candidates of diverse backgrounds, women, and young investigators to apply.


  • SCI Nodal Awards ($50,000) 
  • SCI Innovation Awards ($50,000)
  • SCI Pancreatic Cancer Innovation Awards ($50,000)
  • SCI Women’s Cancer Center Innovation Award ($50,000)
  • Shmunis Family Innovation Awards in Cancer Therapeutics ($50,000)
  • Behar Innovation Awards in Sarcoma Research ($50,000)
  • *NEW*  Michael Toshio Cure for Cancer Catalyst Award (SCI-CC)- $100,000



  • Bold and creative research projects
  • Research related to cancer health equity
  • Research related to leukemia, lymphoma, melanoma, sarcoma, breast, GI, pancreatic, liver, lung cancers
  • Multi-disciplinary collaboration, including collaborations involving Stanford faculty beyond the School of Medicine or inter-programmatic collaborations across the seven SCI research programs
  • Potential to lead to an Investigator-initiated clinical trial
  • Plans for submission of an external peer-reviewed (preferably NCI) application 


RFA Announced: March 15, 2024
Notification of Selection: August 2024
Funding Period: October 1, 2024 – September 30, 2025